Dynavax Technologies
DVAX
$11.17
Share price
-2.19%
Change (1 day)
4.10%
Change (1 year)
Categories
Earnings for Dynavax Technologies (DVAX)
Earnings in 2023 (TTM): $2.66 M
According to Dynavax Technologies 's latest financial reports the company's current earnings (TTM) are $2.66 M. a decrease over its 2022 earnings that were of $0.30 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Dynavax Technologies from 2004 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $2.66 M | -99.11% |
| 2022 | $0.30 B | 238.78% |
| 2021 | $88.69 M | -257.89% |
| 2020 | -$56.18 M | -58.58% |
| 2019 | -$0.14 B | -9.32% |
| 2018 | -$0.15 B | 60.44% |
| 2017 | -$93.22 M | -15.8% |
| 2016 | -$0.12 B | 4.22% |
| 2015 | -$0.11 B | 16.54% |
| 2014 | -$91.15 M | 37.09% |
| 2013 | -$66.49 M | |
| 2010 | -$47.59 M | 214.85% |
| 2009 | -$15.12 M | -37.33% |
| 2008 | -$24.12 M | -66.07% |
| 2007 | -$71.1 M | 16.92% |
| 2006 | -$60.81 M | 170.36% |
| 2005 | -$22.49 M | 33.39% |
| 2004 | -$16.86 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | 122,397.19% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | 294,425.68% | 🇺🇸 USA |
 Biogen BIIB | $1.29 B | 48,523.92% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.85 B | 257,080.35% | 🇺🇸 USA |
 Merck MRK | $3.03 B | 113,698.28% | 🇺🇸 USA |
 AstraZeneca AZN | $8.49 B | 318,422.68% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $7.53 B | 282,427.93% | 🇬🇧 UK |
 Agenus
AGEN | -$0.16 B | -6,080.95% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 15,085.60% | 🇮🇱 Israel |